Indivior, US45579U1097

Indivior stock after-hours at EUR 31.90: plus 0.63 percent versus prior close

Published on 10/05/2026 at 20:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Indivior stock was at EUR 31.90 in after-hours trading at Lang & Schwarz at 8:25 p.m. CEST on October 5, 2026, up plus 0.63 percent versus the prior close. The company declared a conditional special dividend.
Indivior PLC mit ISIN GB00BYZ0C031 betreibt moderne Pharma-Produktionsanlage für innovative Suchtmedizin-Präparate weltweit an Patienten, Illustration mit AI erstellt.

Indivior stock was at EUR 31.90 in after-hours trading at Lang & Schwarz at 8:25 p.m. CEST on October 5, 2026. The price was up plus EUR 0.20, or plus 0.63 percent, versus the Lang & Schwarz prior close of EUR 31.70 on October 2, 2026.

After-hours indication

The euro price remained above the prior close in the after-hours session. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Indivior stock.

Special dividend tied to merger

In a September 17, 2026 release, Indivior said its board had declared a special cash dividend of USD 8.13 per share for holders of record on October 30, 2026. Payment is contingent on the closing of the pending merger with Supernus Pharmaceuticals, which the company expected to complete on or about November 2, 2026. If completed, payment was anticipated on or about November 6, 2026.

Regulatory status

A September 16, 2026 filing by Indivior Pharmaceuticals, Inc. identified Artemis Merger Sub as its wholly owned subsidiary and said the merger would make Supernus a wholly owned subsidiary of Indivior. Separately, the Federal Trade Commission listed the transaction as granted on September 21, 2026.

Disclaimer...
en | US45579U1097 | INDIVIOR | boerse | 70236127 | bgmi